Quest Diagnostics
DGX
#895
Rank
โ‚น2.611 T
Marketcap
โ‚น23,665
Share price
3.68%
Change (1 day)
48.68%
Change (1 year)
Quest Diagnostics is an American clinical laboratory company offering access to diagnostic testing services for cancer, cardiovascular disease, infectious disease, neurological disorders and employment and court ordered drug testing.

Earnings for Quest Diagnostics (DGX)

Earnings in 2026 (TTM): โ‚น122.90 Billion

According to Quest Diagnostics 's latest financial reports the company's current earnings are โ‚น11.27 Billion. In 2025 the company made an earning of โ‚น126.45 Billion, an increase over its 2024 earnings that were of โ‚น112.73 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Quest Diagnostics from 1997 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) โ‚น122.90 B-2.81%
2025 โ‚น126.45 B12.17%
2024 โ‚น112.73 B3.98%
2023 โ‚น108.41 B-8.5%
2022 โ‚น118.49 B-52.48%
2021 โ‚น249.36 B37.95%
2020 โ‚น180.76 B75.09%
2019 โ‚น103.23 B16.2%
2018 โ‚น88.84 B-10.1%
2017 โ‚น98.82 B-5.16%
2016 โ‚น104.19 B-1.54%
2015 โ‚น105.82 B31%
2014 โ‚น80.78 B-37.52%
2013 โ‚น129.30 B26.93%
2012 โ‚น101.87 B24.01%
2011 โ‚น82.15 B-27.7%
2010 โ‚น113.63 B-3.55%
2009 โ‚น117.81 B19.59%
2008 โ‚น98.51 B12.54%
2007 โ‚น87.54 B-11.7%
2006 โ‚น99.13 B13.49%
2005 โ‚น87.35 B9.02%
2004 โ‚น80.12 B13.19%
2003 โ‚น70.78 B36.03%
2002 โ‚น52.03 B63.07%
2001 โ‚น31.91 B65.49%
2000 โ‚น19.28 B1297.84%
1999 โ‚น1.37 B-73.37%
1998 โ‚น5.18 B-384.21%
1997 -โ‚น1.83 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
LabCorp
LH
โ‚น131.94 B-0.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Translate Bio
TBIO.defunct
โ‚น3.99 B-96.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Psychemedics
PMD
-โ‚น0.19 Billion-100.14%๐Ÿ‡บ๐Ÿ‡ธ USA
NeoGenomics
NEO
-โ‚น9.55 Billion-107.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Qiagen
QGEN
โ‚น47.35 B-64.13%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
Enzo Biochem
ENZB
-โ‚น0.76 Billion-100.57%๐Ÿ‡บ๐Ÿ‡ธ USA